Matthew Killeen
Chief Tech/Sci/R&D Officer bei RENOVACOR, INC.
Profil
Matthew Killeen is currently the Director at Sudden Cardiac Arrest Foundation, Advisor-Scientific Affairs at CREAGRI, Inc., and Chief Scientific Officer at Renovacor, Inc. He previously worked as the Head-Cardiovascular Research at BioMarin Pharmaceutical, Inc. and as a Principal at Eli Lilly & Co. Ltd.
Killeen holds a doctorate degree from the University of Cambridge and an undergraduate degree from the University of Leeds.
Aktive Positionen von Matthew Killeen
| Unternehmen | Position | Beginn |
|---|---|---|
| RENOVACOR, INC. | Chief Tech/Sci/R&D Officer | 01.09.2021 |
CREAGRI, Inc.
 CREAGRI, Inc. Food RetailRetail Trade CREAGRI, Inc. develops and supplies antioxidant polyphenols. Its products are used for functional foods, health and dietary supplements. The company was founded by Roberto Crea in 1998 and is headquartered in Hayward, CA. | Corporate Officer/Principal | 12.05.2011 |
| Sudden Cardiac Arrest Foundation | Director/Board Member | - |
Ehemalige bekannte Positionen von Matthew Killeen
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | - |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Matthew Killeen
| University of Cambridge | Doctorate Degree |
| University of Leeds | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Eli Lilly & Co. Ltd. provides pharmaceutical health care solutions. It provide products for cardiovascular, dermatology, diabetes, endocrine, musculoskeletal, neuroscience, oncology and urology. The company was incorporated on April 9, 1963 and is headquartered in Basingstoke, the United Kingdom. | Health Technology |
CREAGRI, Inc.
CREAGRI, Inc. Food RetailRetail Trade CREAGRI, Inc. develops and supplies antioxidant polyphenols. Its products are used for functional foods, health and dietary supplements. The company was founded by Roberto Crea in 1998 and is headquartered in Hayward, CA. | Retail Trade |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
| Sudden Cardiac Arrest Foundation |
